Soleus Capital Management’s Terns Pharmaceuticals TERN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$30.5M	Hold	8,167,100	–	–	2.02%	13
2025 Q1	$22.5M	Buy	8,167,100 +24,600	+0.3%	+$67.9K	1.62%	18
2024 Q4	$45.1M	Buy	8,142,500 +1,918,956	+31%	+$10.6M	2.83%	9
2024 Q3	$51.9M	Buy	6,223,544 +1,275,806	+26%	+$10.6M	4.02%	3
2024 Q2	$33.7M	Buy	+4,947,738	New	+$33.7M	2.97%	6